Clinical Trials Browser

Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Nasopharyngeal Carcinoma, Neoplastic Cells, Circulating

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Thyroid Neoplasms

Squamous Cell Carcinoma of Head and Neck

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Lymphoid Interstitial Pneumonia, Head and Neck Neoplasms, Laryngeal Diseases

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, Neoplasm Metastasis

Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Head and Neck Neoplasms

Nasopharyngeal Carcinoma

Head and Neck Neoplasms, Neoplasms

Nasopharyngeal Carcinoma

Clinical Trials

LIGHT

Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

PLATINUM

DIAMOND

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Metastatic Nasopharyngeal Carcinoma

GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.

Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

GEMSTONE

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

PIPER

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

NPC-Nivo

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients

GNT Induction Treatment in Locally Advanced NPC

Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC

Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

CONTINUUM

Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma